# Disulfiram in Rheumatoid Arthritis

> **NCT07534332** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Oklahoma** · enrollment: 20 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Inflammation
- Obesity

## Interventions

- **DRUG:** Placebo
- **DRUG:** Disulfiram (DSF)

## Key facts

- **NCT ID:** NCT07534332
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07534332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07534332, "Disulfiram in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07534332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*